Eltrombopag Drugs Market Revenue 2024 to 2034
Eltrombopag Drugs Market Revenue 2024 to 2034
The global eltrombopag drugs market was estimated at US$ 2.28 billion in 2023 and is projected to grow to US$ 5.28 billion by 2034, rising at a compound annual growth rate (CAGR) of 7.94% from 2024 to 2034. The demand for eltrombopag is increasing due increasing demand in cancer treatment. During cancer treatment, the number of platelets decreases, due to which eltrombopag is used.
Report ID: 10286
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 2.46 Bn
Forecast Year,
USD USD 5.28 Bn
CAGR, 2025 -
7.94%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Eltrombopag Drugs Market Size Analysis
Eltrombopag Drugs Market Size By Type 2024 to 2034 (USD )
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tablets | 1845.00 | 1986.18 | 2138.15 | 2301.73 | 2477.81 | 2667.34 | 2871.35 | 3090.93 | 3327.29 | 3581.69 | 3855.51 |
| Oral Suspension | 615.00 | 669.14 | 728.00 | 791.99 | 861.56 | 937.17 | 1019.37 | 1108.70 | 1205.80 | 1311.33 | 1426.01 |
Eltrombopag Drugs Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals and Clinic | 1230.00 | 1322.35 | 1421.61 | 1528.30 | 1642.97 | 1766.21 | 1898.67 | 2041.02 | 2194.02 | 2358.43 | 2535.13 |
| Pharmacy | 861.00 | 934.67 | 1014.62 | 1101.37 | 1195.50 | 1297.63 | 1408.44 | 1528.67 | 1659.11 | 1800.63 | 1954.16 |
| Other | 369.00 | 398.30 | 429.92 | 464.06 | 500.91 | 540.68 | 583.61 | 629.95 | 679.96 | 733.95 | 792.23 |
Eltrombopag Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 885.60 | 950.61 | 1020.35 | 1095.18 | 1175.46 | 1261.58 | 1353.97 | 1453.08 | 1559.38 | 1673.41 | 1795.72 |
| Asia Pacific | 664.20 | 724.90 | 791.06 | 863.15 | 941.70 | 1027.29 | 1120.53 | 1222.10 | 1332.73 | 1453.23 | 1584.46 |
| Europe | 541.20 | 586.83 | 636.29 | 689.90 | 748.02 | 811.02 | 879.30 | 953.32 | 1033.54 | 1120.50 | 1214.75 |
| Latin America | 196.80 | 209.77 | 223.56 | 238.22 | 253.79 | 270.34 | 287.91 | 306.57 | 326.38 | 347.40 | 369.71 |
| Middle East and Africa | 172.20 | 183.22 | 194.90 | 207.28 | 220.40 | 234.29 | 249.01 | 264.58 | 281.05 | 298.47 | 316.89 |
Eltrombopag Drugs Market Revenue 2024 to 2034
Eltrombopag Drugs Market Revenue 2024 to 2034
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
